Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
EV/Core EBITDA

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 11.296.365.920.110.35

What is the latest EV/Core EBITDA ratio of WINDLAS BIOTECH ?

The latest EV/Core EBITDA ratio of WINDLAS BIOTECH is 11.29 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202411.29
Mar20236.36
Mar20225.92
Mar20210.11
Mar20200.35

How is EV/Core EBITDA of WINDLAS BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2024 11.29
77.52
Mar2023 6.36
7.43
Mar2022 5.92
5,281.82
Mar2021 0.11
-68.57
Mar2020 0.35 -

Other Financial Ratios of WINDLAS BIOTECH


Compare EV/Core EBITDA ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,993.0 Cr -2.6% -6.8% 77.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,379.0 Cr 0.8% 7.2% 22.2% Stock Analytics
DIVIS LABORATORIES ₹163,420.0 Cr 0.7% 11% 53.3% Stock Analytics
CIPLA ₹122,010.0 Cr -2% 4.6% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,634.0 Cr -1.6% 2.8% 24.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,788.5 Cr -1.4% 0.7% -5.5% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-2.6%

-6.8%

77.5%

SENSEX

0.5%

4.2%

8%


You may also like the below Video Courses